The store will not work correctly when cookies are disabled.
2-(1-phenyldodecylidene)hydrazinecarbothioamide
ID: ALA4472027
PubChem CID: 101008272
Max Phase: Preclinical
Molecular Formula: C19H31N3S
Molecular Weight: 333.55
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCCCCCCCCCC/C(=N\NC(N)=S)c1ccccc1
Standard InChI: InChI=1S/C19H31N3S/c1-2-3-4-5-6-7-8-9-13-16-18(21-22-19(20)23)17-14-11-10-12-15-17/h10-12,14-15H,2-9,13,16H2,1H3,(H3,20,22,23)/b21-18+
Standard InChI Key: KKDDLYILOFMZLV-DYTRJAOYSA-N
Molfile:
RDKit 2D
23 23 0 0 0 0 0 0 0 0999 V2000
24.4854 -2.4226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4843 -3.2422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1923 -3.6511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9020 -3.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8992 -2.4190 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1905 -2.0138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6103 -3.6492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3174 -3.2395 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.0258 -3.6470 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7328 -3.2373 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4412 -3.6448 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7315 -2.4201 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
26.6116 -4.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9046 -4.8761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9058 -5.6933 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1988 -6.1030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2001 -6.9202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4930 -7.3299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4943 -8.1471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7872 -8.5568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.7885 -9.3740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0814 -9.7837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.0827 -10.6009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
8 9 1 0
9 10 1 0
10 11 1 0
10 12 2 0
7 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.55 | Molecular Weight (Monoisotopic): 333.2239 | AlogP: 5.14 | #Rotatable Bonds: 12 |
Polar Surface Area: 50.41 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 11.67 | CX Basic pKa: 2.62 | CX LogP: 6.21 | CX LogD: 6.21 |
Aromatic Rings: 1 | Heavy Atoms: 23 | QED Weighted: 0.24 | Np Likeness Score: -0.80 |
References
1. Hałdys K, Latajka R.. (2019) Thiosemicarbazones with tyrosinase inhibitory activity., 10 (3): [PMID:31015905] [10.1039/C9MD00005D] |